NEW YORK (GenomeWeb) — CancerLinQ has entered into an agreement with Tempus and Precision HealthAI to accelerate development and delivery of high-quality, deidentified clinical databases, CancerLinQ said yesterday.

The databases are intended for use by CancerLinQ, a non-profit subsidiary of the American Society of Clinical Oncology, as well as its oncologist subscribers, partners, and the broader cancer community. They will be made available through the core CancerLinQ quality improvement platform and the organization's CancerLinQ Discovery service.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.